MannKind Corp (MNKD) stock
MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30127% above fair value
$4.07+0.12 (+2.91%)
Close on Nov 17, 2026Market cap $1.31BP/E –Yield –
MannKind pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
MannKind's pe ratio was 141.5× on Apr 30, 2026, against 50.4× a year earlier. Over the last 3 years it ranged from 0.6× to 164.0×, with a median of 50.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 141.5× | +84.8 |
| 2025 | Dec 31, 2025 | 56.7× | −23.7 |
| 2024 | Dec 31, 2024 | 80.4× | +77.9 |
| 2017 | Oct 31, 2017 | 2.4× | – |
See a number that looks wrong?